Eris Lifesciences

ERIS

₹ 1,210.29

₹ 32.42

2.75%

Healthcare

₹ 0.00

(%)1D

Updated: 31 Jan 2025, 02:16:36 pm IST

Stock Score

Open Price

₹ 1,186.70

Prev. Close

₹ 1,177.87

₹ 1,184.41

Day Low

₹ 1,239.16

Day High

₹ 809.39

52 Week Low

₹ 1,579.02

52 Week High

Quick Bite

Price To Earnings Ratio 41.99	Sector PE 65.50
PB Ratio 6.38	Sector PB 8.27
EPS 28.82	Dividend Yield 0.00
Today's Volume 124.978 K	5 Day Avg. Volume 82.937 K
PEG Ratio 16.53	Market Cap. ₹ 16,370.00 Cr.

Eris Lifesciences Share Price

Eris Lifesciences Limited is an Indian company primarily engaged in the production and distribution of pharmaceutical products. The company's manufacturing facility is located in Guwahati, Assam. Its therapeutic areas include oral diabetes, cardiac, pain/analgesic, gynecology, gastrointestinal, central nervous system (CNS) and vitamins, minerals and nutrients (VMN). The company's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cybex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The company's 100% subsidiaries are Kinedex Healthcare Private Limited, Aprica Healthcare Limited and Eris Healthcare Private Limited.

Eris Lifesciences FAQs

How to Buy Eris Lifesciences Share?

To purchase Eris Lifesciences shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Eris Lifesciences (ticker symbol: ERIS) on the trading platform provided by your broker and purchase the shares.

What's Eris Lifesciences share price today?

The stock price of Eris Lifesciences as of 31 Jan 2025 is ₹1,210.29

What is the Market Cap of Eris Lifesciences?

Market capitalisation represents the total market value of a company's outstanding shares. As of 31 Jan 2025, Eris Lifesciences (ticker symbol: ERIS) has a market capitalisation of approximately ₹1,63,70,00,00,000.00

What is the PE and PB ratio of Eris Lifesciences?

Eris Lifesciences Ltd's price-to-book ratio as of 31 Jan 2025 is 6.38, reflecting the market's valuation compared to its asset value. As of 31 Jan 2025, the trailing twelve months P/E (price-to-earnings) ratio is 41.99, indicating the market values the company at around ₹41.99 for every ₹1 of earnings

What is the 52 Week High and Low of Eris Lifesciences Share?

Eris Lifesciences Ltd (ERIS) hit its 52-week high at ₹1,579.02, and its 52-week low at ₹809.39.

Want to learn and earn in Stocks?

View All Global Indices